NCT07644715 AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis
| NCT ID | NCT07644715 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier Pitie-Salpetriere |
| Condition | Arrhythmia |
| Study Type | OBSERVATIONAL |
| Enrollment | 127,000 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 127,000 participants in total. It began in 2026-01-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome and immune checkpoint inhibitor (ICI)-induced myocarditis. The project uses existing and ongoing national and international ECG cohorts with de-identified clinical metadata; AI outputs are intended for research/model development and are not used to drive patient care during the study.
Eligibility Criteria
Inclusion Criteria: * subjects included in participating existing or ongoing ECG cohorts made available to ECGInsight * availability of ECG data (digital waveform or scanned/paper ECG suitable for digitization) and relevant clinical/demographic metadata * data use permitted by applicable ethical, regulatory, contractual and GDPR requirements. Exclusion Criteria: * datasets or individual records for which required approvals, data-sharing agreements, de-identification/anonymization, or minimum ECG/metadata quality requirements are not met. No interventional study treatment is assigned.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07644715 clinical trial?
This trial is open to participants of all sexes, studying Arrhythmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07644715 currently recruiting?
Yes, NCT07644715 is actively recruiting participants. Contact the research team at joe-elie.salem@aphp.fr for enrollment information.
Where is the NCT07644715 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07644715 clinical trial?
NCT07644715 is sponsored by Groupe Hospitalier Pitie-Salpetriere. The trial plans to enroll 127,000 participants.